Blog
RSS FeedPosted by Michael Wonder on 10 Jun 2025
Research funding and more treatment options to support the fight against MND
9 June 2025 - The Australian Government is providing a further $4.5 million and listing another treatment to ensure the ...
Posted by Michael Wonder on 10 Jun 2025
DoH publishes revised agenda for July 2025 PBAC meeting (version 4)
10 June 2025 - The DoH has published a revised agenda for next month's PBAC meeting. ...
Posted by Michael Wonder on 05 Jun 2025
TGA approves weight loss drug to treat sleep disorder
4 June 2025 - The country’s medicines regulator has approved the use of a GLP-1 weight-loss drug to treat people ...
Posted by Michael Wonder on 04 Jun 2025
DoH publishes revised agenda for May 2025 PBAC meeting in June!
4 June 2025 - The DoH has published a revised agenda for last month's PBAC meeting. ...
Posted by Michael Wonder on 01 Jun 2025
Schedule of Pharmaceutical Benefits - 1 June 2025
1 June 2025 - The June 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 22 May 2025
New Alzheimer’s drug available today for Australian patients
22 May 2025 - A new drug to treat the early stages of Alzheimer’s disease has been approved for use ...
Posted by Michael Wonder on 21 May 2025
Lilly's Kisunla (donanemab) receives marketing authorisation in Australia for the treatment of early symptomatic Alzheimer's disease
21 May 2025 - The authorisation in Australia is for adult patients who are Apolipoprotein E-ε4 heterozygotes or non-carriers. ...
Posted by Michael Wonder on 17 May 2025
Outcome statement - April 2025 DUSC meeting
16 May 2025 - The outcome statement from the April 2025 DUSC meeting is now available. ...
Posted by Michael Wonder on 09 May 2025
DoH publishes revised agenda for the July 2025 PBAC meeting
9 May 2025 - The agenda for the July 2025 PBAC meeting has been updated. ...
Posted by Michael Wonder on 04 May 2025
Government lists life-changing epilepsy drug fenfluramine on PBS
4 May 2025 - For the Sutton family, finding a drug that controlled four-year-old daughter Layla’s rare form of epilepsy was ...
Posted by Michael Wonder on 02 May 2025
DoH publishes revised agenda for the May 2025 PBAC meeting
2 May 2025 - The agenda for the May 2025 PBAC meeting has been updated. ...
Posted by Michael Wonder on 28 Apr 2025
Come to grips’: fighting lymphoma from home
28 April 2025 - Australian patients with the most common form of lymphoma will for the first time have access ...
Posted by Michael Wonder on 27 Apr 2025
Public Summary Documents (first time decisions not to recommend and deferrals) – December 2024 PBAC meeting
24 April 2025 - The Public Summary Documents (first-time decisions not to recommend and deferrals) from the December 2024 PBAC meeting ...
Posted by Michael Wonder on 27 Apr 2025
Recommendations made by the PBAC – March 2025
24 April 2025 - Recommendations made by the PBAC in March 2025 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 25 Apr 2025
Multiple myeloma drug subsidised after treatment costs ballooned
24 April 2025 - It’s one of the few cancers still considered incurable, and those diagnosed with multiple myeloma will likely ...